Invest now
Phaarmasia share price
Extreme risk
You have to be logged in to add this to Watchlist.- ₹92.00(-0.43%)October 8, 2026 11:21:39 AM IST
- NSE
- BSE
- Vol : 0.00 K (NSE + BSE)Last 20 day avg : 0.61 K
Phaarmasia is trading -0.43% lower at Rs 92.00 as compared to its last closing price. Phaarmasia has been trading in the price range of 92.00 & 92.00. Phaarmasia has given -18.04% in this year & 5.00% in the last 5 days. Phaarmasia has TTM P/E ratio 3.87 as compared to the sector P/E of 33.81.The company posted a net profit of 0.34 Crores in its last quarter.Listed peers of Phaarmasia include Sun Pharmaceutical Industries (-1.72%), Divi's Laboratories (-1.99%), Torrent Pharmaceuticals (-0.74%).The Mutual Fund holding in Phaarmasia was at -% in . The MF holding has - from the last quarter. The FII holding in Phaarmasia was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 08 Oct 2026, 04:36 PM IST
- BetaHigh volatility2.60Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.05The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.03The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Phaarmasia Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,752.50 | -1.72 | 4,20,473.54 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 9,389.00 | -1.99 | 2,49,248.45 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,675.00 | -0.74 | 1,77,815.61 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,305.00 | -1.84 | 1,05,425.52 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,115.20 | -3.36 | 1,11,241.63 | 21.19 | 4.24 | 0.09 | 14.22 |
Phaarmasia Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-13 | Quarterly Results & A.G.M. |
| 2026-05-29 | Audited Results |
| 2026-02-06 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
About the company Phaarmasia
- IndustryBiotechnology & Drugs
- ISININE486I01016
- BSE Code523620
- NSE Code
Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
Phaarmasia Share Price FAQs
Phaarmasia is trading at 92.00 as on Thu Oct 08 2026 05:51:39. This is -0.43% lower as compared to its previous closing price of 92.40.
The market capitalization of Phaarmasia is 62.80 Cr as on Thu Oct 08 2026 05:51:39.
The 52 wk high for Phaarmasia is 131.75 whereas the 52 wk low is 30.01
Phaarmasia can be analyzed on the following key metrics -
- TTM P/E: 3.87
- Sector P/E: 33.81
- Dividend Yield: 0.00%
- D/E ratio: -
Phaarmasia reported a net profit of 17.57 Cr in 2026.
Quick Links
EQUITY QUICK LINKS
Phaarmasia QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.